TrialHaematologica2012

Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia.

Harry Iland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.